Physician
Zorub, Ossama
Zorub, Ossama was paid $1.96M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 51% of everything it billed.
33Billing provider infoZORUB, OSSAMA
MICHIGAN CITY, IN 46360
MICHIGAN CITY, IN 46360
33aNPI1891769303assigned 02/14/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.96M
24GClaims36,271
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Indiana
Rank by total paid#26 of 316
Median peer was paid$17K
This provider vs. median116×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 455 | $23K | |
| 2019 | 910 | $46K | |
| 2020 | 2,742 | $125K | |
| 2021 | 2,343 | $116K | |
| 2022 | 3,161 | $184K | |
| 2023 | 10,524 | $570K | |
| 2024incomplete | 16,136 | $893K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 51% | 13,509 | 10,156 | $999K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 18% | 1,054 | 896 | $355K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.0% | 1,145 | 982 | $97K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.8% | 4,093 | 3,553 | $95K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.7% | 1,842 | 1,624 | $92K |
| 36410 | 3.2% | 4,229 | 3,475 | $63K | |
| 87581 | 2.2% | 1,044 | 907 | $43K | |
| 87486 | 2.2% | 1,044 | 907 | $43K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.7% | 389 | 345 | $33K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 450 | 379 | $18K |
| 99386 | <1% | 142 | 131 | $15K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 238 | 218 | $12K |
29 more codes
| 99490 | Ccm add 20min | <1% | 1,016 | $11K |
| 96127 | <1% | 748 | $11K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 107 | $9K |
| 81000 | <1% | 2,836 | $8K | |
| 99385 | <1% | 72 | $7K | |
| 86769 | <1% | 152 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 367 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 103 | $5K |
| 93923 | <1% | 62 | $3K | |
| 99439 | <1% | 326 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 53 | $3K |
| 99397 | <1% | 32 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 24 | $2K |
| 95923 | <1% | 54 | $2K | |
| 95921 | <1% | 53 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 207 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 57 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 41 | $2K |
| 93000 | <1% | 119 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 66 | $1K |
| 96368 | <1% | 41 | $748.66 | |
| 99457 | <1% | 144 | $520.66 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 41 | $469.86 |
| 99454 | <1% | 175 | $349.24 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 20 | $42.11 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 80 | $14.70 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 71 | $9.10 |
| 99453 | 0% | 13 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.